The effect of decontamination procedures on the pharmacokinetics of venlafaxine in overdose

Clinical Pharmacology and Therapeutics

Volumn 86, Issue 4, 2009, Pages 403-410

  Kumar, V V P ^a   Oscarsson, S ^b   Friberg, L E ^b   Isbister, G K ^c,d   Hackett, L P ^e   Duffull, S B ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UPPSALA UNIVERSITY   (Sweden)

^c Newcastle Mater Hospital   (United Kingdom)

^d MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^e PATHWEST LABORATORY MEDICINE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED CARBON; VENLAFAXINE;

ADOLESCENT; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DETOXIFICATION; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG HALF LIFE; DRUG OVERDOSE; FEMALE; HUMAN; INTESTINE LAVAGE; MAJOR CLINICAL STUDY; MALE; MAXIMUM PLASMA CONCENTRATION; PRIORITY JOURNAL; SINGLE DRUG DOSE; SLOW RELEASE FORMULATION;

ADOLESCENT; ADULT; AGED; AREA UNDER CURVE; CHARCOAL; CYCLOHEXANOLS; DECONTAMINATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; IRRIGATION; LOWER GASTROINTESTINAL TRACT; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; MODELS, BIOLOGICAL; OVERDOSE; PROSPECTIVE STUDIES; SEROTONIN UPTAKE INHIBITORS; YOUNG ADULT;

EID: 70349462945     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2009.114     Document Type: Article

References (21)

1. Kessler, R.C., Chiu, W.T., Demler, O., Merikangas, K.R. & Walters, E.E. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 62, 617-627 (2005). (Pubitemid 40973437)
2. McKenzie, M.S. & McFarland, B.H. Trends in antidepressant overdoses. Pharmacoepidemiol. Drug Saf. 16, 513-523 (2007).
3. Whyte, I.M., Dawson, A.H. & Buckley, N.A. Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants. QJM 96, 369-374 (2003).
4. Isbister, G.K. Electrocardiogram changes and arrhythmias in venlafaxine overdose. Br. J. Clin. Pharmacol. 67, 572-576 (2009).
5. Buckley, N.A. & McManus, P.R. Fatal toxicity of serotoninergic and other antidepressant drugs: analysis of United Kingdom mortality data. BMJ 325, 1332-1333 (2002).
6. Chyka, P.A. & Seger, D. Position statement: single-dose activated charcoal. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. J. Toxicol. Clin. Toxicol. 35, 721-741 (1997).
7. Friberg, L.E., Isbister, G.K., Hackett, L.P. & Duffull, S.B. The population pharmacokinetics of citalopram after deliberate self-poisoning: a Bayesian approach. J. Pharmacokinet. Pharmacodyn. 32, 571-605 (2005).
8. Isbister, G.K., Friberg, L.E., Hackett, L.P. & Duffull, S.B. Pharmacokinetics of quetiapine in overdose and the effect of activated charcoal. Clin. Pharmacol. Ther. 81, 821-827 (2007).
9. Friberg, L.E., Isbister, G.K. & Duffull, S.B. Pharmacokinetic- pharmacodynamic modelling of QT interval prolongation following citalopram overdoses. Br. J. Clin. Pharmacol. 61, 177-190 (2006).
10. Hudson, D. & Djogovic, D. Alternate venlafaxine kinetics in overdose patients. J. Clin. Pharm. Ther. 32, 109 (2007).
11. Mégarbane, B., Bloch, V., Deye, N. & Baud, F.J. Pharmacokinetic/pharmacodynamic modelling of cardiac toxicity in venlafaxine overdose. Intensive Care Med. 33, 195-196; author reply 197 (2007).
12. Position paper: whole bowel irrigation. J. Toxicol. Clin. Toxicol. 42, 843-854 (2004).
13. Ilett, K.F. et al. Distribution and excretion of venlafaxine and O-desmethylvenlafaxine in human milk. Br. J. Clin. Pharmacol. 45, 459-462 (1998).
14. Spiegelhalter, D.J., Thomas, A., Best, N. & Lunn, D. WinBUGS User Manual Version 1.4 (Imperial College School of Medicine, London, 2003).
15. Duffull, S.B., Kirkpatrick, C.M., Green, B. & Holford, N.H. Analysis of population pharmacokinetic data using NONMEM and WinBUGS. J. Biopharm. Stat. 15, 53-73 (2005)
16. Friberg, L.E., Dansirikul, C. & Duffull, S.B. Simultaneous fit of competing models as a model discrimination tool in Bayesian analysis. Technical report (School of Pharmacy, University of Queensland, Brisbane, Australia, 2004).
17. Friberg, L.E., Dansirikul, C. & Duffull, S.B. Simultaneous fit of competing models as a model discrimination tool in Bayesian analysis. (School of Pharmacy, University of Queensland, Brisbane, Australia, 2006).
18. Kumar, V.V. & Duffull, S.B. Methods to account for inaccuracies in the dosing history when performing population pharmacokinetic analysis. Pharm. Res. 25, 2740-2749 (2008).
19. Dansirikul, C., Morris, R.G., Tett, S.E. & Duffull, S.B. A Bayesian approach for population pharmacokinetic modelling of sirolimus. Br. J. Clin. Pharmacol. 62, 420-434 (2006).
20. Gelman, A., Carlin, J.B., Stern, H.S. & Rubin, D.B. Bayesian data analysis, (Chapman & Hall/CRC, Boca Raton, 2003).
21. Comets, E., Brendel, K. & Mentre, F. Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: the npde addon package for R. Comput. Methods Programs Biomed. 90, 154-166 (2008).